1,132
Views
8
CrossRef citations to date
0
Altmetric
Addendum

Novel insights into the disease etiology of laminopathies

, &
Article: e27002 | Received 01 Aug 2013, Accepted 30 Oct 2013, Published online: 06 Nov 2013

References

  • Schreiber KH, Kennedy BK. When lamins go bad: nuclear structure and disease. Cell 2013; 152:1365 - 75; http://dx.doi.org/10.1016/j.cell.2013.02.015; PMID: 23498943
  • Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G, Toniolo D. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 1994; 8:323 - 7; http://dx.doi.org/10.1038/ng1294-323; PMID: 7894480
  • Vaughan A, Alvarez-Reyes M, Bridger JM, Broers JL, Ramaekers FC, Wehnert M, Morris GE, Hutchison CJ, Hutchison CJ, Whitfield WGF. Both emerin and lamin C depend on lamin A for localization at the nuclear envelope. J Cell Sci 2001; 114:2577 - 90; PMID: 11683386
  • Muchir A, Medioni J, Laluc M, Massart C, Arimura T, van der Kooi AJ, Desguerre I, Mayer M, Ferrer X, Briault S, et al. Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve 2004; 30:444 - 50; http://dx.doi.org/10.1002/mus.20122; PMID: 15372542
  • Zwerger M, Jaalouk DE, Lombardi ML, Isermann P, Mauermann M, Dialynas G, Herrmann H, Wallrath LL, Lammerding J. Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling. Hum Mol Genet 2013; 22:2335 - 49; http://dx.doi.org/10.1093/hmg/ddt079; PMID: 23427149
  • Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 2004; 113:370 - 8; PMID: 14755334
  • Lammerding J, Hsiao J, Schulze PC, Kozlov S, Stewart CL, Lee RT. Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol 2005; 170:781 - 91; http://dx.doi.org/10.1083/jcb.200502148; PMID: 16115958
  • Cupesi M, Yoshioka J, Gannon J, Kudinova A, Stewart CL, Lammerding J. Attenuated hypertrophic response to pressure overload in a lamin A/C haploinsufficiency mouse. J Mol Cell Cardiol 2010; 48:1290 - 7; http://dx.doi.org/10.1016/j.yjmcc.2009.10.024; PMID: 19913544
  • Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999; 147:913 - 20; http://dx.doi.org/10.1083/jcb.147.5.913; PMID: 10579712
  • Mounkes LC, Kozlov SV, Rottman JN, Stewart CL. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet 2005; 14:2167 - 80; http://dx.doi.org/10.1093/hmg/ddi221; PMID: 15972724
  • Ho CY, Jaalouk DE, Vartiainen MK, Lammerding J. Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics. Nature 2013; 497:507 - 11; http://dx.doi.org/10.1038/nature12105; PMID: 23644458
  • Parmacek MS. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ Res 2007; 100:633 - 44; http://dx.doi.org/10.1161/01.RES.0000259563.61091.e8; PMID: 17363709
  • Olson EN, Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 2010; 11:353 - 65; http://dx.doi.org/10.1038/nrm2890; PMID: 20414257
  • Small EM. The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation. J Cardiovasc Transl Res 2012; 5:794 - 804; http://dx.doi.org/10.1007/s12265-012-9397-0; PMID: 22898751
  • Sun Y, Boyd K, Xu W, Ma J, Jackson CW, Fu A, Shillingford JM, Robinson GW, Hennighausen L, Hitzler JK, et al. Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function. Mol Cell Biol 2006; 26:5809 - 26; http://dx.doi.org/10.1128/MCB.00024-06; PMID: 16847333
  • Kuwahara K, Kinoshita H, Kuwabara Y, Nakagawa Y, Usami S, Minami T, Yamada Y, Fujiwara M, Nakao K. Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol Cell Biol 2010; 30:4134 - 48; http://dx.doi.org/10.1128/MCB.00154-10; PMID: 20606005
  • Hirano H, Matsuura Y. Sensing actin dynamics: structural basis for G-actin-sensitive nuclear import of MAL. Biochem Biophys Res Commun 2011; 414:373 - 8; http://dx.doi.org/10.1016/j.bbrc.2011.09.079; PMID: 21964294
  • Pawłowski R, Rajakylä EK, Vartiainen MK, Treisman R. An actin-regulated importin α/β-dependent extended bipartite NLS directs nuclear import of MRTF-A. EMBO J 2010; 29:3448 - 58; http://dx.doi.org/10.1038/emboj.2010.216; PMID: 20818336
  • Belaguli NS, Schildmeyer LA, Schwartz RJ. Organization and myogenic restricted expression of the murine serum response factor gene. A role for autoregulation. J Biol Chem 1997; 272:18222 - 31; http://dx.doi.org/10.1074/jbc.272.29.18222; PMID: 9218459
  • Chien R. Signaling mechanisms for the activation of an embryonic gene program during the hypertrophy of cardiac ventricular muscle. Basic Res Cardiol 1992; 87:Suppl 2 49 - 58; PMID: 1299210
  • Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 1997; 80:11A 15L - 25L; http://dx.doi.org/10.1016/S0002-9149(97)00845-X; PMID: 9412539
  • Durand JB. Genetic basis of cardiomyopathy. Curr Opin Cardiol 1999; 14:225 - 9; http://dx.doi.org/10.1097/00001573-199905000-00006; PMID: 10358794
  • Arsenian S, Weinhold B, Oelgeschläger M, Rüther U, Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J 1998; 17:6289 - 99; http://dx.doi.org/10.1093/emboj/17.21.6289; PMID: 9799237
  • Parlakian A, Charvet C, Escoubet B, Mericskay M, Molkentin JD, Gary-Bobo G, De Windt LJ, Ludosky MA, Paulin D, Daegelen D, et al. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Circulation 2005; 112:2930 - 9; PMID: 16260633
  • Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, Jogia D, Kesteven SH, Michalicek J, Otway R, Verheyen F, et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 2004; 113:357 - 69; PMID: 14755333
  • Hale CM, Shrestha AL, Khatau SB, Stewart-Hutchinson PJ, Hernandez L, Stewart CL, Hodzic D, Wirtz D. Dysfunctional connections between the nucleus and the actin and microtubule networks in laminopathic models. Biophys J 2008; 95:5462 - 75; http://dx.doi.org/10.1529/biophysj.108.139428; PMID: 18790843
  • Morita T, Mayanagi T, Sobue K. Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs). Exp Cell Res 2007; 313:3432 - 45; http://dx.doi.org/10.1016/j.yexcr.2007.07.008; PMID: 17714703
  • Stewart CL, Kozlov S, Fong LG, Young SG. Mouse models of the laminopathies. Exp Cell Res 2007; 313:2144 - 56; http://dx.doi.org/10.1016/j.yexcr.2007.03.026; PMID: 17493612
  • Roncarati R, Viviani Anselmi C, Krawitz P, Lattanzi G, von Kodolitsch Y, Perrot A, di Pasquale E, Papa L, Portararo P, Columbaro M, et al. Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet 2013; 21:1105 - 11; http://dx.doi.org/10.1038/ejhg.2013.16; PMID: 23463027
  • Quijano-Roy S, Mbieleu B, Bönnemann CG, Jeannet PY, Colomer J, Clarke NF, Cuisset JM, Roper H, De Meirleir L, D’Amico A, et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol 2008; 64:177 - 86; http://dx.doi.org/10.1002/ana.21417; PMID: 18551513
  • Vytopil M, Ricci E, Dello Russo A, Hanisch F, Neudecker S, Zierz S, Ricotti R, Demay L, Richard P, Wehnert M, et al. Frequent low penetrance mutations in the Lamin A/C gene, causing Emery Dreifuss muscular dystrophy. Neuromuscul Disord 2002; 12:958 - 63; http://dx.doi.org/10.1016/S0960-8966(02)00178-5; PMID: 12467752
  • Cattin ME, Bertrand AT, Schlossarek S, Le Bihan MC, Skov Jensen S, Neuber C, Crocini C, Maron S, Lainé J, Mougenot N, et al. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity. Hum Mol Genet 2013; 22:3152 - 64; http://dx.doi.org/10.1093/hmg/ddt172; PMID: 23575224
  • Zhang J, Lian Q, Zhu G, Zhou F, Sui L, Tan C, Mutalif RA, Navasankari R, Zhang Y, Tse HF, et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011; 8:31 - 45; http://dx.doi.org/10.1016/j.stem.2010.12.002; PMID: 21185252
  • Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, Dimaio JM, Sadek H, Kuwahara K, Olson EN. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 2010; 107:294 - 304; http://dx.doi.org/10.1161/CIRCRESAHA.110.223172; PMID: 20558820
  • Luchsinger LL, Patenaude CA, Smith BD, Layne MD. Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts. J Biol Chem 2011; 286:44116 - 25; http://dx.doi.org/10.1074/jbc.M111.276931; PMID: 22049076
  • Holaska JM, Kowalski AK, Wilson KL. Emerin caps the pointed end of actin filaments: evidence for an actin cortical network at the nuclear inner membrane. PLoS Biol 2004; 2:E231; http://dx.doi.org/10.1371/journal.pbio.0020231; PMID: 15328537
  • Raharjo WH, Enarson P, Sullivan T, Stewart CL, Burke B. Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J Cell Sci 2001; 114:4447 - 57; PMID: 11792810
  • Baarlink C, Wang H, Grosse R. Nuclear actin network assembly by formins regulates the SRF coactivator MAL. Science 2013; 340:864 - 7; http://dx.doi.org/10.1126/science.1235038; PMID: 23558171
  • de Lanerolle P. Nuclear actin and myosins at a glance. J Cell Sci 2012; 125:4945 - 9; http://dx.doi.org/10.1242/jcs.099754; PMID: 23277533
  • Belin BJ, Cimini BA, Blackburn EH, Mullins RD. Visualization of actin filaments and monomers in somatic cell nuclei. Mol Biol Cell 2013; 24:982 - 94; http://dx.doi.org/10.1091/mbc.E12-09-0685; PMID: 23447706
  • Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, Bonne G, Worman HJ. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest 2007; 117:1282 - 93; http://dx.doi.org/10.1172/JCI29042; PMID: 17446932
  • Muchir A, Wu W, Worman HJ. Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells. Biochim Biophys Acta 2009; 1792:75 - 81; http://dx.doi.org/10.1016/j.bbadis.2008.10.012; PMID: 19022376
  • Muchir A, Pavlidis P, Bonne G, Hayashi YK, Worman HJ. Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Hum Mol Genet 2007; 16:1884 - 95; http://dx.doi.org/10.1093/hmg/ddm137; PMID: 17567779
  • Muchir A, Shan J, Bonne G, Lehnart SE, Worman HJ. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet 2009; 18:241 - 7; http://dx.doi.org/10.1093/hmg/ddn343; PMID: 18927124
  • Wu W, Muchir A, Shan J, Bonne G, Worman HJ. Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation 2011; 123:53 - 61; http://dx.doi.org/10.1161/CIRCULATIONAHA.110.970673; PMID: 21173351
  • Kirkwood JM, Bastholt L, Robert C, Sosman J, Larkin J, Hersey P, Middleton M, Cantarini M, Zazulina V, Kemsley K, et al. Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma. Clin Cancer Res 2012; 18:555 - 67; http://dx.doi.org/10.1158/1078-0432.CCR-11-1491; PMID: 22048237
  • Muchir A, Reilly SA, Wu W, Iwata S, Homma S, Bonne G, Worman HJ. Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene. Cardiovasc Res 2012; 93:311 - 9; http://dx.doi.org/10.1093/cvr/cvr301; PMID: 22068161
  • Muehlich S, Wang R, Lee SM, Lewis TC, Dai C, Prywes R. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization. Mol Cell Biol 2008; 28:6302 - 13; http://dx.doi.org/10.1128/MCB.00427-08; PMID: 18694962
  • Cattin ME, Muchir A, Bonne G. ‘State-of-the-heart’ of cardiac laminopathies. Curr Opin Cardiol 2013; 28:297 - 304; http://dx.doi.org/10.1097/HCO.0b013e32835f0c79; PMID: 23455585